Re: "Ethics and sample size"

被引:3
作者
Halpern, SD [1 ]
Karlawish, JHT
Berlin, JA
机构
[1] Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA
[2] Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA
[3] Univ Penn, Sch Med, Ctr Educ & Res Therapeut, Philadelphia, PA 19104 USA
[4] Univ Penn, Sch Med, Ctr Bioeth, Philadelphia, PA 19104 USA
[5] Johnson & Johnson Pharmaceut Res & Dev LLC, Titusville, NJ 08560 USA
关键词
D O I
10.1093/aje/kwi176
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 [公共卫生与预防医学]; 120402 [社会医学与卫生事业管理];
摘要
引用
收藏
页码:195 / U1
页数:2
相关论文
共 4 条
[1]
Bacchetti P, 2005, AM J EPIDEMIOL, V161, P105, DOI 10.1093/aje/kwi014
[2]
Hypertensive patients' willingness to participate in placebo-controlled trials: Implications for recruitment efficiency [J].
Halpern, SD ;
Karlawish, JHT ;
Casarett, D ;
Berlin, JA ;
Townsend, RR ;
Asch, DA .
AMERICAN HEART JOURNAL, 2003, 146 (06) :985-992
[3]
The continuing unethical conduct of underpowered clinical trials [J].
Halpern, SD ;
Karlawish, JHT ;
Berlin, JA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (03) :358-362
[4]
Invited commentary: Ethics and sample size - Another view [J].
Prentice, R .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2005, 161 (02) :111-112